← Eichor
Condition: Thymoma And Thymic Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Thymoma And Thymic Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06885697Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06301945PT-112 in Subjects With Thymoma and Thymic Carcinoma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05104736First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Art
Phase 2 · 1 location(s) · National Cancer Center, Japan · NCT05832827Hypofractionated Radiotherapy for Thymic Epithelial Tumors
NA · 1 location(s) · Rongrong Zhou · NCT06692062HEARTS Trial for Thoracic Cancers
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT07132918Molecular Analysis and Treatment Options of Thymic Malignancies
Phase N/A · 1 location(s) · Shanghai Chest Hospital · NCT05667948Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03295227CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07181720A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Phase 2 · 4 location(s) · Georgetown University · NCT06248515Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Phase 2 · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT06019468Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors
Phase 2 · 1 location(s) · Jian Chen · NCT06186726Ivonescimab for the Treatment of Thymic Cancer
Phase 2 · 5 location(s) · Jonsson Comprehensive Cancer Center · NCT06980077Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06838910Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07598955Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
Phase 3 · 1 location(s) · Fudan University · NCT06402708Study on Proton Radiotherapy of Thymic Malignancies
NA · 3 location(s) · Ass. Prof. Jan Nyman · NCT04822077
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.